$VICL - Bounce watch. Vical is seeking a partner for further development. The company's Vaxfectin(R)-formulated CyMVectin(TM) prophylactic vaccine, designed to prevent CMV infection before and during pregnancy, has completed preclinical development and has an allowed investigational new drug application (IND).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.